Metabolic engineering of cell cultures versus whole plant complexity in production of bioactive monoterpene indole alkaloids: recent progress related to old dilemma.

J Biosci Bioeng

Programa de Pós-graduação em Biologia Celular e Molecular, Centro de Biotecnologia, Universidade Federal do Rio Grande do Sul, Av. Bento Gonçalves 9500, Pr. 43.431, P.O. Box 15.005, CEP 91.501-970, Porto Alegre, RS, Brazil.

Published: April 2006

Monoterpene indole alkaloids (MIAs) are a large class of plant alkaloids with significant pharmacological interest. The sustained production of MIAs at high yields is an important goal in biotechnology. Intensive effort has been expended toward the isolation, cloning, characterization and transgenic modulation of genes involved in MIA biosynthesis and in the control of the expression of these biosynthesis-related genes. At the same time, considerable progress has been made in the detailed description of the subcellular-, cellular-, tissue- and organ-specific expressions of portions of the biosynthetic pathways leading to the production of MIAs, revealing a complex picture of the transport of biosynthetic intermediates among membrane compartments, cells and tissues. The identification of the particular environmental and ontogenetic requirements for maximum alkaloid yield in MIA-producing plants has been useful in improving the supply of bioactive molecules. The search for new bioactive MIAs, particularly in tropical and subtropical regions, is continuously increasing the arsenal for therapeutic, industrially and agriculturally useful molecules. In this review we focus on recent progress in the production of MIAs in transgenic cell cultures and organs (with emphasis on Catharanthus roseus and Rauvolfia serpentina alkaloids), advances in the understanding of in planta spatial-temporal expression of MIA metabolic pathways, and on the identification of factors capable of modulating bioactive alkaloid accumulation in nontransgenic differentiated cultures and plants (with emphasis on new MIAs from Psychotria species). The combined use of metabolic engineering and physiological modulation in transgenic and wild-type plants, although not fully exploited to date, is likely to provide the sustainable and rational supply of bioactive MIAs needed for human well being.

Download full-text PDF

Source
http://dx.doi.org/10.1263/jbb.101.287DOI Listing

Publication Analysis

Top Keywords

production mias
12
metabolic engineering
8
cell cultures
8
monoterpene indole
8
indole alkaloids
8
supply bioactive
8
bioactive mias
8
mias
7
bioactive
5
engineering cell
4

Similar Publications

Monoterpene indole alkaloids (MIAs) are a large, structurally diverse class of bioactive natural products. These compounds are biosynthetically derived from a stereoselective Pictet-Spengler condensation that generates a tetrahydro-β-carboline scaffold characterized by a 3 stereocenter. However, a subset of MIAs contain a non-canonical 3 stereocenter.

View Article and Find Full Text PDF

Voagafries A-E, undescribed indole alkaloids with anti-glioma activity from Voacanga africana.

Phytochemistry

March 2025

School of Pharmaceutical Science & Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, 650500, China; Yunnan College of Modern Biomedical Industry, Kunming Medical University, Kunming, 650500, China. Electronic address:

Voagafries A-E, five undescribed monoterpenoid indole alkaloids (MIAs), were isolated from the stem bark of Voacanga africana. Voagafrie A (1) has a unique 6/5/5/6/6 spiral ring skeleton with an indolone-fused 9-oxo-3-aza-tricyclo[6,3,1,0]-12-alkane-10-carbonyllactone. Voagafrie B (2) is a rare 5,6-seco diazine scaffold, whereas voagafrie C (3) possesses an octahydropyrrolo[2,3-b] pyrrole-fused 2,8-diazabicyclo[3.

View Article and Find Full Text PDF
Article Synopsis
  • Camptothecin (CAM) is a complex plant-derived compound known for its antitumor properties and is part of a family of monoterpene indole alkaloids (MIAs) that includes other anticancer drugs like vinblastine and vincristine.
  • Researchers have established a new in vivo enzyme assay to characterize two key enzymes involved in the biosynthesis of MIAs, focusing on the transformation of nepetalactol to 7-deoxyloganic acid, which is difficult to detect due to the instability of intermediates.
  • The study identified and characterized two cytochrome P450 enzymes and two glycosyltransferases from Camptotheca acuminata, which are responsible for key enzym
View Article and Find Full Text PDF
Article Synopsis
  • * This study focuses on the biosynthesis of rare MIAs in the Tabernaemontana litoralis plant, identifying new CYP enzymes that specifically modify MIA structures, including the discovery of a new MIA compound.
  • * The research enhances our understanding of how MIAs are synthesized and diversified in T. litoralis, suggesting its potential for future studies in this area.
View Article and Find Full Text PDF
Article Synopsis
  • Plant-specialized metabolism is a rich source of bioactive compounds, like monoterpene indole alkaloids (MIAs), known for their health benefits including anticancer and neuroactive properties.
  • The types of MIAs, particularly pachysiphine derivatives, have promising medical applications but are found in very low quantities in certain plant species, and there is a lack of genomic data needed to enhance their production.
  • This study presents the genome sequence of the toad tree (Tabernaemontana elegans) and identifies genes that can synthesize pachysiphine, leading to engineered MIAs in yeast, thus paving the way for better production of these valuable compounds for pharmaceutical use.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!